UnknownNot Applicable

The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort

France600 participantsStarted 2017-05-01

Plain-language summary

The national drug safety agency authorizes nominatively the use of sodium thiosulfate in dialysis patients with calciphylaxis. To date, it is the largest global cohort (more 600 patients from 2012 to 2016). We wanted to study retrospectively the fate of these patients at 6 months including mortality. Early use improves effectiveness.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All dialysis patients with calciphylaxis in France who have obtained a temporary use authorization for sodium thiosulfate by National Agency for the Safety of Medicines Exclusion Criteria: * N/A

What they're measuring

Mortality

Timeframe: 6 months

Trial details

NCT IDNCT03146793

SponsorCentre Hospitalier St Esprit

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-12-31

Contact for this trial

Albert TRINH-DUC, MD

0033675743871 albert.trinh-duc@wanadoo.fr

View on ClinicalTrials.gov More Calciphylaxis trials